Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related
1 clinical trials · Condition
◉ Watch Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related
| Record | Firm | Date |
|---|---|---|
| Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT02890329) | National Cancer Institute (NCI) | 2017-09-05 |
Track Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related automatically
Every clearance here is in the API, with alerts when new ones post.